Portola Pharmaceuticals appoints David Stump to its Board of Directors
– USA, CA – Portola Pharmaceuticals (Nasdaq:PTLA) today announced the appointment of David C.…
– USA, CA – Portola Pharmaceuticals (Nasdaq:PTLA) today announced the appointment of David C.…
– USA, MA – Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, has appointed Donald K.…
– USA, PA – Strongbridge Biopharma plc announced today that Garheng Kong, M.D.,…
– USA, MA – Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Jeffrey S.…
– USA, PA – Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of acute post operative pain, today announced the appointment of Karen A.…